Skip to search formSkip to main contentSkip to account menu

Cilazapril

Known as: 6H-Pyridazino(1,2-a)(1,2)diazepine-1-carboxylic acid, 9-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)octahydro-10-oxo-, monohydrate, (1S-(1alpha,9alpha(R*)))-, CILAZAPRIL MONOHYDRATE, Cilazapril Hydrate 
A pyridazine angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. As a prodrug, cilazapril is rapidly metabolized in the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1996
Highly Cited
1996
To gain insight into the contribution of immunologic and hemodynamic factors in the progressive demise of structure and function… 
1996
1996
To investigate whether angiotensin-converting enzyme inhibitor (ACE-I) potentially alleviates hyperdipsia, the effect of… 
1993
1993
Endothelium-dependent dilatation of cerebral arterioles is impaired during chronic hypertension. The goal of this study was to… 
Highly Cited
1992
Highly Cited
1992
A multicenter, randomized double-blind study of 6 months' duration was performed in 540 patients (average age 54 years, 57% male… 
1991
1991
Both heparin and the angiotensin converting enzyme inhibitor cilazapril inhibit intimal thickening in rat carotid arteries… 
1988
1988
The antihypertensive effects and pharmacokinetic properties of cilazapril, a long-acting angiotensin-converting enzyme (ACE… 
Highly Cited
1987
Highly Cited
1987
Summary: Cilazapril 1.25 and 5.0 mg p.o. q.d. was administered in double-blind fashion to two groups of six normal volunteers on… 
1986
1986
In a double-blind, placebo controlled, crossover study 12 patients with essential hypertension received single doses of 5, 10 and…